19 results
8-K
EX-10.1
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules
5:01pm
, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the Company’s Knowledge, is threatened
PRE 14A
781e 6gt5ka3n3m
12 Apr 23
Preliminary proxy
4:07pm
DEF 14A
bb4var6o1e8
27 Apr 22
Definitive proxy
4:10pm
10-K
hvj8xo qs75u3cj
29 Mar 22
Annual report
4:15pm
10-Q
cel5o77ves6fv xjreiw
12 Aug 21
Quarterly report
4:22pm
424B4
fnraj6x1vwflmddoh2
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
7v6ip8i
9 Jun 21
IPO registration (amended)
4:51pm
S-1
wz6qhwu
4 Jun 21
IPO registration
9:07am
S-1
EX-10.4
nsdvuz
4 Jun 21
IPO registration
9:07am
DRS/A
22bo68661xuk2o 4h
21 May 21
Draft registration statement (amended)
12:00am
DRS
kk891
19 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next